NEW YORK, Sept. 30 - Venture capitalists turned their backs on privately held genomics companies during the third quarter as private-equity markets sought solace among drug discoverers and developers, according to an industry report.
...and receive Daily News bulletins.
Already have an account?Login Now.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.